Study Information
Locations
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
The goal of this project is to document incidence and risk factors for lung cancer by smoking status, among AANHPIs, focusing especially on female never smokers.
PIs are Scarlett Lin Gomez, Ph.D., MPH, and Iona Cheng, Ph.D., MPH, both with UCSF.
Site PI is Su-Ying Liang, Ph.D.
Principal Investigator
External PI, Principal Investigator
Co-Investigator(s)
Funder
NIH, National Cancer Institute
Related Studies
Breast Cancer Chemoprevention in Primary Care at Geisinger
Investigators: Xiaowei (Sherry) Yan, PhD, MS, External PI, Principal Investigator
COVID-19 Impacts on Cancer Care Management, Patient Experience and Care Costs
Investigators: Cheryl Stults, Ph.D., Monique de Bruin, M.D., MPH, Su-Ying Liang, Ph.D.
Cancer Liquid Biopsy Monitoring Study
Investigators: Mohammed Kashani-Sabet, M.D., Deepti Behl, MD
Coverage, Price, and Reimbursement for Multigene Tests for Cancer and Related Conditions
Investigator: Su-Ying Liang, Ph.D.
Impact of COVID-19 on Cancer Care Management
Investigators: Monique de Bruin, M.D., MPH, Su-Ying Liang, Ph.D.
Implementing Universal Lynch Syndrome Screening Across Multiple Healthcare Systems: Identifying Strategies to Facilitate and Maintain Programs in Different Organizations Contexts
Investigators: Su-Ying Liang, Ph.D., Monique de Bruin, M.D., MPH, External PI, Principal Investigator
Improving Cancer Care
Investigators: Su-Ying Liang, Ph.D., Ellis C. Dillon, Ph.D.
Multilevel Study of Lung Cancer Screening Guidelines Implementation (MUST)
Investigator: Jiang Li, Ph.D., MPH
Stupski Serious Illness Program Evaluation
Investigators: Sylvia Sudat, PhD, Ellis C. Dillon, Ph.D.